Episode 7. Tom Armitage holds a PhD in earth sciences from University College London (UCL) and completed his undergraduate and masters degrees at UCL as well. Tom previously worked with the European Space Agency and recently completed postdoctoral training at the NASA Jet Propulsion Laboratory (JPL) and the University of Maryland. He is an incoming consultant at Boston Consulting Group.
Episode 6. Amit Srivastava is a Senior Director at Pfizer. He did a PhD in genetics and cell biology at Carnegie Mellon University and postdoc at Boston Children's Hospital. After launching a startup company, Amit worked in strategy consulting at Boston Consulting Group (BCG) and worked in vaccine development at the Bill and Melinda Gates Foundation.
Episode 5. Paul Bromann is the host of the Illumina Genomics Podcast and Senior Manager of Scientific Affairs at Illumina. He did his PhD in neuroscience at Northwestern University and postdocs at Sanford-Burnham Prebys and Van Andel Institute. He's had extensive industry experience, including a stint as a Medical Science Liaison at Bristol-Meyers-Squibb.
Episode 3. Audrey Sporrij is a PhD student in stem cell biology in a joint program between Harvard University and Utrecht University. She is co-president of the Harvard GSAS Consulting Club and has volunteered as a business development and alliance management fellow at the Harvard University Office of Technology and Development.
Episode 2. Daniel Pham is an Associate Director at the Milken Institute Center for Strategic Philanthropy. He did a PhD in neuroscience at Johns Hopkins University, where he founded Project Bridge, a student organization focused on scientific outreach. After his PhD, Daniel worked in science communication at Research!America and as a Public Affairs Manager at the American Society for Biochemistry and Molecular Biology (ASBMB).
Episode 1. Nick Edwards is the host of the Once a Scientist podcast. He trained as a neuroscientist and did his PhD at Brown University and the NIH. After completing a postdoc at UCSD, he went to Boston Consulting Group (BCG), where he worked in strategy consulting. More recently, he moved back to San Diego to work in the biotech industry doing commercial strategy.